EP
SRZN icon

Eversept Partners’s Surrozen SRZN Stock Holding History

Eversept Partners’s Portfolio SRZN Stock Details SRZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Sell
58,624
-36,662
-38% -$879K 0.09% 93
2025
Q4 		$2.15M Buy
95,286
+18,289
+24% +$296K 0.11% 86
2025
Q3 		$992K Buy
+76,997
New +$807K 0.07% 77

Other funds holding SRZN

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM

Eversept Partners's SRZN Position: Q1 2026 in Review

Eversept Partners reduced its Surrozen (SRZN) stake by 38% in Q1 2026, selling an estimated $879K and leaving 58,624 shares worth $1.71M. The position accounts for 0.09% of the portfolio, ranked #93.

Eversept Partners first reported a position in SRZN in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.15M in Q4 2025. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Eversept Partners held 58,624 shares of Surrozen worth $1.71M as of Q1 2026.
  • Eversept Partners sold 36,662 Surrozen shares in Q1 2026, an estimated $879K.
  • Surrozen made up 0.09% of Eversept Partners's portfolio in Q1 2026, its #93 holding.
  • Eversept Partners first reported a position in Surrozen in Q3 2025 and has held it in 3 quarters since.
  • Eversept Partners's Surrozen position peaked at $2.15M in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.